Escalon Medical Corp. (ESMC)

Escalon Medical Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	3.07	0.55	0.21	0.89	0.59
Cash & Short-Term Investments	3.07	0.55	0.21	0.89	0.59
Cash Growth	461.61%	161.12%	-76.50%	49.81%	-64.03%
Receivables	1.9	1.5	2.12	1.65	1.54
Inventory	1.73	2.14	1.61	1.59	1.6
Restricted Cash	-	0.26	0.26	0.26	0.26
Other Current Assets	0.31	0.16	0.19	0.25	0.19
Total Current Assets	7.01	4.61	4.4	4.64	4.19
Property, Plant & Equipment	0.85	0.29	0.25	0.54	0.84
Other Intangible Assets	0.01	0.03	0.05	0.07	0.08
Long-Term Deferred Tax Assets	1.14	-	-	-	-
Other Long-Term Assets	0.11	0.06	0.06	0.06	0.06
Total Assets	9.13	4.99	4.76	5.31	5.17

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	0.93	1.39	1.36	1.21	1.01
Accrued Expenses	0.74	0.67	0.63	0.63	0.88
Short-Term Debt	-	-	-	-	0.2
Current Portion of Long-Term Debt	0	0.04	0.04	0.04	0.01
Current Portion of Leases	0.16	0.09	0.21	0.33	0.3
Current Income Taxes Payable	0.04	0.04	0.04	0.1	0.1
Current Unearned Revenue	0.39	0.33	0.28	0.43	0.33
Other Current Liabilities	0.12	0.13	0.12	0.12	0.16
Total Current Liabilities	2.39	2.69	2.67	2.85	3
Long-Term Debt	0.14	0.22	0.27	0.31	0.15
Long-Term Leases	0.68	0.17	0.01	0.21	0.54
Total Liabilities	3.2	3.08	2.95	3.37	3.69

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	69.7	69.7	69.7	69.7	69.7
Retained Earnings	-64.43	-68.44	-68.54	-68.42	-68.88
Total Common Equity	5.28	1.27	1.16	1.29	0.83
Shareholders' Equity	5.93	1.92	1.81	1.93	1.48
Total Liabilities & Equity	9.13	4.99	4.76	5.31	5.17

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	0.97	0.52	0.52	0.89	1.21
Net Cash (Debt)	2.09	0.02	-0.32	-0	-0.61
Net Cash Growth	9178.93%	-	-	-	-
Net Cash Per Share	0.14	0.00	-0.04	-0.00	-0.08
Filing Date Shares Outstanding	7.42	7.42	7.42	7.42	7.42
Total Common Shares Outstanding	7.42	7.42	7.42	7.42	7.42
Working Capital	4.62	1.93	1.73	1.78	1.18
Book Value Per Share	0.71	0.17	0.16	0.17	0.11
Tangible Book Value	5.27	1.24	1.12	1.22	0.75
Tangible Book Value Per Share	0.71	0.17	0.15	0.16	0.10
Machinery	0.95	0.95	0.96	0.91	0.9
Leasehold Improvements	0.04	0.04	0.04	0.04	0.04

Data Source: S&P Global Market Intelligence Last updated: Oct 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error